Yes. That is when they will evaluate the results to that point and once they obtain break-through therapy that means they were able to shrink the tumor and then CiaB's value is worth even more than it is just for Pancreatic Cancer. Stay confident, avoid the noise, keep your shares and enjoy your profits while humans are being helped.
News 
Market Data 
Discover 
AI
